Found 20 matching trials
Opicapone as Adjunctive Therapy to Levodopa-Carbidopa Intestinal Gel in Parkinson's Disease
NALevodopa-Carbidopa intestinal gel (LCIG) is an effective therapy for compli...
Location
University Hospital of Ferrara - Arcispedale Sant'Anna
Open Label Continuation Treatment Study With Levodopa-Carbidopa Intestinal Gel in Advanced Parkinson's Disease
PHASE3The primary objective of this study is to provide continued access to levod...
Location
University of Alabama at Birmingham /ID# 49941
Health Related Quality of Life in LCIG Patients and LCIG Eligible Patients Continuing Oral Therapy
N/AThe aim of this study is to assess the effect of LCIG (levodopa-carbidopa i...
Location
Universitaetsklinikum Aachen /ID# 204355
A Sequential Two-Part, Open-Label Study in Healthy Male and Female Subjects
PHASE1An Open-Label Study in Healthy Male and Female Subjects to Identify the Con...
Location
Quotient Clinical LTD
Study of Efficacy, Safety and Tolerability of Levodopa-Carbidopa Intestinal Gel in Levodopa-Responsive Parkinson's Subjects
PHASE3The primary objective of this study was to demonstrate the superiority of l...
Location
Site Reference ID/Investigator# 45719
Long-term Study of Duodopa (Levodopa/Carbidopa) in Advanced Parkinson's: Health Outcomes & Net Economic Impact
PHASE4The primary objective of this study is to collect health economic data depi...
Location
Multiple Locations
Patient- and Caregiver-reported Symptoms and Outcomes With Levodopa/Carbidopa Intestinal Gel for the Treatment of Advanced Parkinson's Disease
N/APatient reported outcomes (PRO) have become an important endpoint assessed ...
Location
Multiple Locations
Levodopa-Carbidopa Intestinal Gel Open-Label Study in Advanced Parkinson's Disease
PHASE3The primary objective of this study will be to provide further evidence of ...
Location
Site Reference ID/Investigator# 50065
COmedication Study Assessing Mono- and cOmbination Therapy With Levodopa-carbidopa inteStinal Gel
N/AThe purpose of this study is to evaluate treatment of advanced Parkinson's ...
Location
Gailtal Klinik /ID# 202505
Safety/Efficacy Study of Levodopa-Carbidopa Intestinal Gel in Parkinson's Subjects
PHASE3Long term safety and efficacy (12 months) of levodopa-carbidopa intestinal ...
Location
Site Reference ID/Investigator# 45869